Prescription drug · BLA
Hympavzi (Marstacimab-hncq) NDC 0069-2151
Marstacimab 150 mg/mL · Injection, Solution · Subcutaneous · Pfizer Laboratories Div Pfizer Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0069-2151-01 | 00069215101 | 1 SYRINGE in 1 CARTON (0069-2151-01) / 1 mL in 1 SYRINGEMarketed from Nov 5, 2024 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Hympavzi
- Generic name (nonproprietary)
- marstacimab-hncq
- Active ingredients
- Marstacimab — 150 mg/mL
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Labeler
- Pfizer Laboratories Div Pfizer IncNDC labeler code 0069
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 761369
- Marketing start
- Listing expires
- Identifiers
- Product ID 0069-2151_23101437-0c06-4577-aca1-32535c6f7056SPL ID 23101437-0c06-4577-aca1-32535c6f7056SPL set ID a2cc631e-13a6-40c2-acf9-065ccedfb90aRxCUI 2697139, 2697146, 2697150, 2697154, 2745185, 2745186, 2745187, 2745188UNII 0UB3OA67O7
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400069215101followed by a unit qualifier and the quantityPackage 00069-2151-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
HYMPAVZI is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients 6 years of age and older with: • hemophilia A (congenital factor VIII deficiency) with or without factor VIII inhibitors, or • hemophilia B (congenital factor IX deficiency) with or without factor IX inhibitors. HYMPAVZI is a tissue factor pathway inhibitor (TFPI) antagonist indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients 6 years of age and older with: • hemophilia A (congenital factor VIII deficiency) with or without factor VIII inhibitors, or • hemophilia B (congenital factor IX defi…
Excerpt only. Read the full label for complete information.
About NDC 0069-2151
- What is NDC 0069-2151?
- 0069-2151 is the product NDC for Hympavzi (marstacimab-hncq), Marstacimab 150 mg/mL injection, solution, listed with the FDA by Pfizer Laboratories Div Pfizer Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Hympavzi (Marstacimab-hncq).
- What is the active ingredient?
- Marstacimab.
- Who is the labeler?
- Pfizer Laboratories Div Pfizer Inc, NDC labeler code 0069. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Hympavzi?
- 2 other product NDCs are listed under this name. See all Hympavzi NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Hympavzi products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Hympavzimarstacimab-hncq | Marstacimab 75 mg/.5mL | Injection, SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-0775 | 00069-0775-01 |
| Hympavzimarstacimab-hncq | Marstacimab 150 mg/mL | Injection, SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1510 | 00069-1510-01 |
Other NDCs under BLA 761369
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Hympavzimarstacimab-hncq | Marstacimab 75 mg/.5mL | Injection, SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-0775 |
| Hympavzimarstacimab-hncq | Marstacimab 150 mg/mL | Injection, SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-1510 |